You are here: Industry Insights > PSP

News List

FDA Grants Orphan Drug Designation for Progressive SupraNuclear Palsy Treatment americanpharmaceuticalreview
March 09, 2020
Retrotope announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for its chemically-modified polyunsaturated fatty acid drug (RT001) ...
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP) b3cnewswire
April 17, 2019
AlzProtect Starts Collaboration with PAREXEL Biotech for Phase 2a of AZP2006 for the Treatment of Progressive Supranuclear Palsy (PSP)
AlzProtect partners with PAREXEL Biotech for PSP March 25, 2019
The partnership will perform the clinical phase 2a development of AZP2006 for the treatment of Progressive Supranuclear Palsy (PSP)
AlzProtect, on Track for a Phase 2 Entry in 2019, for its Drug Candidate AZP2006 b3cnewswire
February 21, 2019
AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of Alzheimer's disease and Progressive Supranuclear Palsy (PSP)....
EnClear Spins out of QurAlis americanpharmaceuticalreview
December 29, 2018
EnClear Therapies has spun-out from QurAlis Corporation, a biotech company focused on developing precision therapeutics for ALS and other neurological diseases. EnClear’s mission is to halt the progression of ....